Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies


Summary

GlobalData's Medical Devices sector report, “Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Continuous Glucose Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Continuous glucose monitoring system is used for the continuous measurement of blood glucose.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Continuous Glucose Monitors under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Continuous Glucose Monitors and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Continuous Glucose Monitors under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Continuous Glucose Monitors Overview
4 Products under Development
4.1 Continuous Glucose Monitors - Pipeline Products by Stage of Development
4.2 Continuous Glucose Monitors - Pipeline Products by Territory
4.3 Continuous Glucose Monitors - Pipeline Products by Regulatory Path
4.4 Continuous Glucose Monitors - Pipeline Products by Estimated Approval Date
4.5 Continuous Glucose Monitors - Ongoing Clinical Trials
5 Continuous Glucose Monitors - Pipeline Products under Development by Companies
5.1 Continuous Glucose Monitors Companies - Pipeline Products by Stage of Development
5.2 Continuous Glucose Monitors – Companies Pipeline Products by Stage of Development
6 Continuous Glucose Monitors Companies and Product Overview
6.1 Abbott Diabetes Care Inc Company Overview
6.1.1 Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 Advanced Biosensors-Ohio LLC Company Overview
6.2.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
6.3 Advanced Medical Electronics Corp Company Overview
6.3.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
6.4 Apollon Inc Company Overview
6.4.1 Apollon Inc Pipeline Products & Ongoing Clinical Trials Overview
6.5 Arkal Medical Inc (Inactive) Company Overview
6.5.1 Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.6 Azurite Technologies, Inc. (Inactive) Company Overview
6.6.1 Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.7 Biovotion AG Company Overview
6.7.1 Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview
6.8 CALISTO MEDICAL, INC. (Inactive) Company Overview
6.8.1 CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.9 CGM3 Ltd Company Overview
6.9.1 CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.1 City, University of London Company Overview
6.10.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview
6.11 Columbia University Company Overview
6.11.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
6.12 ConvaTec Group Plc Company Overview
6.12.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview
6.13 Cyber Medical Ltd (Inactive) Company Overview
6.13.1 Cyber Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.14 DexCom Inc Company Overview
6.14.1 DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview
6.15 Echo Therapeutics Inc Company Overview
6.15.1 Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.16 eLutions Integrated Systems, Inc. Company Overview
6.16.1 eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.17 Flowsion A/S Company Overview
6.17.1 Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview
6.18 Gili Medical Ltd Company Overview
6.18.1 Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.19 Globe Medical Tech Inc (Inactive) Company Overview
6.19.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.2 GlucoLight Corporation (Inactive) Company Overview
6.20.1 GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.21 Glucometrix AG Company Overview
6.21.1 Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview
6.22 Glucosense Diagnostics Ltd (Inactive) Company Overview
6.22.1 Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.23 GlucoTrack Inc Company Overview
6.23.1 GlucoTrack Inc Pipeline Products & Ongoing Clinical Trials Overview
6.24 GluMetrics Inc Company Overview
6.24.1 GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.25 Glusense Ltd Company Overview
6.25.1 Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.26 GlySens Inc Company Overview
6.26.1 GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview
6.27 Guided Therapeutics Inc Company Overview
6.27.1 Guided Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.28 Hagar Tech Company Overview
6.28.1 Hagar Tech Pipeline Products & Ongoing Clinical Trials Overview
6.29 iGlyko, Inc. (Inactive) Company Overview
6.29.1 iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.3 Innovosens AB Company Overview
6.30.1 Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview
6.31 Invivosense ASA (Inactive) Company Overview
6.31.1 Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.32 I-Sens Inc Company Overview
6.32.1 I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview
6.33 Jiangsu Yuyue Medical Equipment & Supply Co Ltd Company Overview
6.33.1 Jiangsu Yuyue Medical Equipment & Supply Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.34 Know Labs Inc Company Overview
6.34.1 Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
6.35 KTH Royal Institute of Technology Company Overview
6.35.1 KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
6.36 LEMM Technologies, LLC Company Overview
6.36.1 LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
6.37 Medical Wireless Sensing Ltd Company Overview
6.37.1 Medical Wireless Sensing Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.38 Medtronic MiniMed Inc Company Overview
6.38.1 Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview
6.39 Metronom Health Inc Company Overview
6.39.1 Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview
6.4 MicroTech Medical Co Ltd Company Overview
6.40.1 MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.41 mobiLIFE Company Overview
6.41.1 mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview
6.42 Nemaura Medical Inc Company Overview
6.42.1 Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.43 Newton Photonics Inc Company Overview
6.43.1 Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.44 Northwestern University Company Overview
6.44.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
6.45 PKvitality SAS Company Overview
6.45.1 PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview
6.46 Purdue University Company Overview
6.46.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
6.47 SD Biosensor Inc Company Overview
6.47.1 SD Biosensor Inc Pipeline Products & Ongoing Clinical Trials Overview
6.48 SensiVida Medical Technologies, Inc. (Inactive) Company Overview
6.48.1 SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.49 Socrates Health Solutions, Inc. Company Overview
6.49.1 Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.5 Stony Brook University Company Overview
6.50.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview
6.51 Swansea University Company Overview
6.51.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview
6.52 Tandem Diabetes Care Inc Company Overview
6.52.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
6.53 Tenax Therapeutics Inc Company Overview
6.53.1 Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.54 Texas A&M University Company Overview
6.54.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview
6.55 Ultradian Diagnostics LLC Company Overview
6.55.1 Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
6.56 University of California Berkeley Company Overview
6.56.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
6.57 University of California Irvine Company Overview
6.57.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
6.58 University of California San Diego Company Overview
6.58.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
6.59 University of South Carolina Company Overview
6.59.1 University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
6.6 University of South Florida Company Overview
6.60.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
6.61 University of Technology Sydney Company Overview
6.61.1 University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview
6.62 University of Texas at Arlington Company Overview
6.62.1 University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview
6.63 Uxn Co Ltd Company Overview
6.63.1 Uxn Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.64 VeriTeQ Corporation Company Overview
6.64.1 VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview
7 Continuous Glucose Monitors- Recent Developments
7.1 Nov 13, 2023: Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
7.2 Nov 07, 2023: Henry Schein to Present at Upcoming Investor Conferences in November 2023
7.3 Oct 23, 2023: Invitation to Senzime’s Third Quarter 2023 Report Presentation
7.4 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
7.5 Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
7.6 Oct 10, 2023: Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023
7.7 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
7.8 Oct 03, 2023: Insulet Announces CFO Transition
7.9 Sep 26, 2023: Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence
7.1 Sep 19, 2023: Lifecare - Sanofi Product Development Agreement Update
7.11 Sep 11, 2023: Nemaura Medical Completes 100 Patient Study for Sugarbeat 24-Hour Wear and Reports Interim Results
7.12 Sep 05, 2023: Henry Schein to Present at Investor Conferences in September 2023
7.13 Aug 31, 2023: Glucotrack Announces the Appointment of Erin Carter to Board of Directors
7.14 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
7.15 Aug 28, 2023: Glucotrack Announces Appointment of Drinda Benjamin as New VP of Marketing
7.16 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
7.17 Aug 18, 2023: Nemaura receives SFDA approval for wearable glucose sensor
7.18 Aug 15, 2023: Convatec Group Appoints Robyn Butler-Mason as Company Secretary
7.19 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
7.2 Aug 02, 2023: ConvaTec Group Announces Interim Results for the six months ended 30 June 2023
7.21 Jul 14, 2023: Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023
7.22 Jul 05, 2023: Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023
7.23 Jun 21, 2023: Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System
7.24 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1
7.25 Jun 07, 2023: Know Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose Monitoring
7.26 May 30, 2023: Know Labs’ Non-Invasive Glucose Monitoring Technology Shows Improved Accuracy
7.27 May 26, 2023: Daewoong’s cumulative CGM sales exceed 600,000 units
7.28 May 17, 2023: Lee's Pharmaceutical Holdings Announces Poll Result of Annual General Meeting; Resignation & Appointment of an Independent Non-executive Director
7.29 May 16, 2023: Senzime Announces Bulletin from annual general meeting
7.3 May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023
7.31 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.32 May 10, 2023: Dexcom showcases accuracy, reliability and ease of use of its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society
7.33 May 08, 2023: Know Labs reports data from feasibility study of Bio-RFID sensor
7.34 May 05, 2023: Senzime's Nomination Committee Adjusts Its Proposal for Resolutions at the Annual General Meeting
7.35 Apr 27, 2023: Dexcom G6 Real-Time CGM System now accessible to any eligible client managing diabetes with insulin through NIHB
7.36 Apr 21, 2023: Invitation to Senzime’s first quarter 2023 report presentation
7.37 Apr 12, 2023: Medtronic has a layoff in California
7.38 Apr 10, 2023: Draper Names Sarah Leeper Vice President and General Manager for Electronic Systems
7.39 Mar 22, 2023: HAGAR announces preliminary results of study for its non invasive glucose monitoring system
7.4 Mar 22, 2023: ConvaTec Group Notice of Annual General Meeting
7.41 Mar 21, 2023: Manitoba becomes a provincial trailblazer in providing simplified Access to advanced glucose monitors
7.42 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
7.43 Mar 09, 2023: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2022
7.44 Feb 24, 2023: Insulet Reports Full Year 2022 Revenue Increase of 19% and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year
7.45 Feb 22, 2023: Dexcom showcases accuracy, simplicity and connectivity of its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally
7.46 Feb 21, 2023: Ascensia Diabetes Care collaborates with SNAQ to support mealtime decision-making for people with diabetes
7.47 Feb 21, 2023: Dexcom G6 Continuous Glucose Monitoring System launches in Singapore
7.48 Feb 16, 2023: Henry Schein Reports Fourth-Quarter and Full-Year 2022 Financial Results and Introduces 2023 Financial Guidance
7.49 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023
7.5 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022
7.51 Feb 02, 2023: Mednow launches new Virtual Diabetes Management Program in partnership with Dexcom
7.52 Feb 01, 2023: Senzime Announces Interim report January-December 2022
7.53 Jan 26, 2023: Senzime’s Announces Invitation to fourth quarter 2022 report presentation
7.54 Jan 23, 2023: Senzime Notice of Extraordinary General Meeting
7.55 Jan 19, 2023: Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
7.56 Jan 18, 2023: DexCom obtains additional 510(k) clearance for Dexcom G6 Continuous Glucose Monitoring System
7.57 Jan 17, 2023: Dexcom G6 Real-Time CGM System now available to all clients with type 1 diabetes covered under the non-insured health benefits program
7.58 Jan 12, 2023: Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
7.59 Dec 12, 2022: Dexcom Canada partners with Green Shield and The Health Depot to offer plan members a comprehensive digital diabetes care experience
7.6 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Continuous Glucose Monitors - Pipeline Products by Stage of Development
Table 2: Continuous Glucose Monitors - Pipeline Products by Territory
Table 3: Continuous Glucose Monitors - Pipeline Products by Regulatory Path
Table 4: Continuous Glucose Monitors - Pipeline Products by Estimated Approval Date
Table 5: Continuous Glucose Monitors - Ongoing Clinical Trials
Table 6: Continuous Glucose Monitors Companies - Pipeline Products by Stage of Development
Table 7: Continuous Glucose Monitors – Companies Pipeline Products by Stage of Development
Table 8: Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Status
Table 10: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Description
Table 11: Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 12: My Medibit - Product Status
Table 13: My Medibit - Product Description
Table 14: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Continuous Glucose Monitor - Product Status
Table 16: Continuous Glucose Monitor - Product Description
Table 17: Apollon Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Raman Spectroscopy - Non-Invasive Continuous Glucose Monitor - Product Status
Table 19: Raman Spectroscopy - Non-Invasive Continuous Glucose Monitor - Product Description
Table 20: Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 21: GlucoPod CGM System - Product Status
Table 22: GlucoPod CGM System - Product Description
Table 23: Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Blood Glucose Sensor - Product Status
Table 25: Blood Glucose Sensor - Product Description
Table 26: Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview
Table 27: VSM 3 Glucose Monitoring System - Product Status
Table 28: VSM 3 Glucose Monitoring System - Product Description
Table 29: CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Glucoband - Product Status
Table 31: Glucoband - Product Description
Table 32: CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Miniaturized Implantable Continuous Glucose Monitor - Product Status
Table 34: Miniaturized Implantable Continuous Glucose Monitor - Product Description
Table 35: City, University of London Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Non-Invasive Glucose Monitor - Product Status
Table 37: Non-Invasive Glucose Monitor - Product Description
Table 38: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Wearable Continuous Blood Glucose Monitoring Device - Product Status
Table 40: Wearable Continuous Blood Glucose Monitoring Device - Product Description
Table 41: ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Closed Loop Continuous Glucose Monitoring System - Product Status
Table 43: Closed Loop Continuous Glucose Monitoring System - Product Description
Table 44: Cyber Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Cybersensors Continuous Glucose Sensor - Product Status
Table 46: Cybersensors Continuous Glucose Sensor - Product Description
Table 47: DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: DexCom CGM With Accu-Chek Insulin Delivery System - Product Status
Table 49: DexCom CGM With Accu-Chek Insulin Delivery System - Product Description
Table 50: First-Gen Verily Sensor - Product Status
Table 51: First-Gen Verily Sensor - Product Description
Table 52: Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Display - Continuous Glucose Monitoring - Product Status
Table 54: Display - Continuous Glucose Monitoring - Product Description
Table 55: Gen 2 Symphony CGM System - Product Status
Table 56: Gen 2 Symphony CGM System - Product Description
Table 57: Symphony tCGM System - Home - Product Status
Table 58: Symphony tCGM System - Home - Product Description
Table 59: Symphony tCGM System - Hospital Critical Care - Product Status
Table 60: Symphony tCGM System - Hospital Critical Care - Product Description
Table 61: eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Optically-Efficient Miniaturized Raman Optical System - Product Status
Table 63: Optically-Efficient Miniaturized Raman Optical System - Product Description
Table 64: Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Glycostat - Product Status
Table 66: Glycostat - Product Description
Table 67: Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Diawatch - Product Status
Table 69: Diawatch - Product Description
Table 70: Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Continuous Glucose Monitoring Device - Product Status
Table 72: Continuous Glucose Monitoring Device - Product Description
Table 73: GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 74: SENTRIS-100 - Product Status
Table 75: SENTRIS-100 - Product Description
Table 76: Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Non-Invasive Blood Glucose Monitoring Device - Product Status
Table 78: Non-Invasive Blood Glucose Monitoring Device - Product Description
Table 79: Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Non-Invasive Blood Glucose Monitor - Product Status
Table 81: Non-Invasive Blood Glucose Monitor - Product Description
Table 82: GlucoTrack Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 83: GlucoTrack - DF-C - Product Status
Table 84: GlucoTrack - DF-C - Product Description
Table 85: GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 86: GluCath Intravascular Continuous Glucose Monitor - Product Status
Table 87: GluCath Intravascular Continuous Glucose Monitor - Product Description
Table 88: Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Glyde CGM - Product Status
Table 90: Glyde CGM - Product Description
Table 91: GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Eclipse ICGM System - Product Status
Table 93: Eclipse ICGM System - Product Description
Table 94: Guided Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 95: Altea MicroPor Laser - Product Status
Table 96: Altea MicroPor Laser - Product Description
Table 97: Hagar Tech Pipeline Products & Ongoing Clinical Trials Overview
Table 98: GWave - Product Status
Table 99: GWave - Product Description
Table 100: GWave 2.0 - Product Status
Table 101: GWave 2.0 - Product Description
Table 102: Hagar Tech - Ongoing Clinical Trials Overview
Table 103: GWave - Study to Evaluate the Accuracy of GWave in Patients with Type 1 and Type 2 diabetes in Israel
Table 104: iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 105: iGlyko System - Product Status
Table 106: iGlyko System - Product Description
Table 107: Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview
Table 108: Diabetic Sensor - Continuous Glucose Monitoring - Product Status
Table 109: Diabetic Sensor - Continuous Glucose Monitoring - Product Description
Table 110: Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 111: IvSCGM Biosensor - Product Status
Table 112: IvSCGM Biosensor - Product Description
Table 113: I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 114: CareSens Air Glucose Monitoring System - Product Status
Table 115: CareSens Air Glucose Monitoring System - Product Description
Table 116: Continuous Blood Glucose Meter - Product Status
Table 117: Continuous Blood Glucose Meter - Product Description
Table 118: Jiangsu Yuyue Medical Equipment & Supply Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 119: Second-Generation CGM System - Product Status
Table 120: Second-Generation CGM System - Product Description
Table 121: Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 122: UBAND - Product Status
Table 123: UBAND - Product Description
Table 124: KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 125: Microneedle Patch - Glucose Monitoring - Product Status
Table 126: Microneedle Patch - Glucose Monitoring - Product Description
Table 127: LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 128: Non-Invasive Blood Glucose Monitor - Product Status(LEMM Technologies, LLC)
Table 129: Non-Invasive Blood Glucose Monitor - Product Description(LEMM Technologies, LLC)
Table 130: Medical Wireless Sensing Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 131: GlucoWiSe - Product Status
Table 132: GlucoWiSe - Product Description
Table 133: Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 6
Table 134: iPro 3 Glucose Monitoring System - Product Status 6
Table 135: iPro 3 Glucose Monitoring System - Product Description 6
Table 136: Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 137: CGM System - Product Status
Table 138: CGM System - Product Description
Table 139: MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 140: AiDex X - Product Status
Table 141: AiDex X - Product Description
Table 142: mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview
Table 143: GlucoReader - Product Status
Table 144: GlucoReader - Product Description
Table 145: Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 146: sugarBEAT - Product Status
Table 147: sugarBEAT - Product Description
Table 148: Nemaura Medical Inc - Ongoing Clinical Trials Overview
Table 149: sugarBEAT - Study is to Compare the sugarBEAT and Major Continuous Glucose Monitor Sensor in People with Diabetes
Table 150: Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 151: Non-invasive Blood Glucose Monitor - Product Status
Table 152: Non-invasive Blood Glucose Monitor - Product Description
Table 153: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
Table 154: Continuous Glucose Sensor - Product Status
Table 155: Continuous Glucose Sensor - Product Description
Table 156: PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 157: K’Watch Glucose - Product Status
Table 158: K’Watch Glucose - Product Description
Table 159: PKvitality SAS - Ongoing Clinical Trials Overview
Table 160: K’Watch Glucose - Clinical Investigation of K'Watch - Lab & Home Study
Table 161: Purdue University Pipeline Products & Ongoing Clinical Trials Overview 6
Table 162: Soft Contact Lens - Product Status 6
Table 163: Soft Contact Lens - Product Description 6
Table 164: SD Biosensor Inc Pipeline Products & Ongoing Clinical Trials Overview 7
Table 165: All-In-One Next-Generation Continuous Glucose Monitoring System - Product Status 7
Table 166: All-In-One Next-Generation Continuous Glucose Monitoring System - Product Description 7
Table 167: Continuous Glucose Monitoring System - Product Status
Table 168: Continuous Glucose Monitoring System - Product Description
Table 169: SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 170: Glucose Monitoring System - Product Status
Table 171: Glucose Monitoring System - Product Description
Table 172: Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 173: Companion CM - Product Status
Table 174: Companion CM - Product Description
Table 175: Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview
Table 176: GlucoREAD Patch - Product Status
Table 177: GlucoREAD Patch - Product Description
Table 178: Swansea University Pipeline Products & Ongoing Clinical Trials Overview
Table 179: Flash Glucose Monitoring Device - Product Status
Table 180: Flash Glucose Monitoring Device - Product Description
Table 181: Hi-Tech Diabetes Blood Glucose Monitor - Product Status
Table 182: Hi-Tech Diabetes Blood Glucose Monitor - Product Description
Table 183: Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 184: Next Generation Closed Loop - Product Status
Table 185: Next Generation Closed Loop - Product Description
Table 186: Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 187: Glucose Biosensor - Product Status
Table 188: Glucose Biosensor - Product Description
Table 189: Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 6
Table 190: Minimally Invasive Glucose Monitoring System - Product Status 6
Table 191: Minimally Invasive Glucose Monitoring System - Product Description 6
Table 192: Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 7
Table 193: Biologue - Product Status 7
Table 194: Biologue - Product Description 7
Table 195: University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 8
Table 196: Dropsense Continuous Glucose Monitor - Product Status 8
Table 197: Dropsense Continuous Glucose Monitor - Product Description 8
Table 198: University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
Table 199: Implantable Device - Diabetes Mellitus - Product Status
Table 200: Implantable Device - Diabetes Mellitus - Product Description
Table 201: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
Table 202: Glucose Monitoring Tattoo - Product Status
Table 203: Glucose Monitoring Tattoo - Product Description
Table 204: University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
Table 205: Conti

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings